Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
1,297
Views
0
CrossRef citations to date
0
Altmetric
Mental Health
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States
Lasair O’Callaghana Sage Therapeutics, Inc., Cambridge, MA, USAhttps://orcid.org/0000-0002-4643-1557
, Elizabeth Chertavianb Medicus Economics, LLC, Milton, MA, USA
, Scott J. Johnsonb Medicus Economics, LLC, Milton, MA, USA
, Erin Ferriesa Sage Therapeutics, Inc., Cambridge, MA, USACorrespondence[email protected]
https://orcid.org/0000-0002-2883-1549
& https://orcid.org/0000-0002-2883-1549
Kristina M. Deligiannidisc Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, New York, NY, USA;d Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA;e Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USAhttps://orcid.org/0000-0001-7439-2236
Pages 492-505
|
Received 05 Feb 2024, Accepted 05 Mar 2024, Published online: 31 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.